Fidelity International

Fidelity International’s Cogent Biosciences COGT Stock Holding History

Fidelity International’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-169,931	Closed	-$313K	–	939
2020 Q2	$313K	Sell	169,931 -25,925	-13%	-$48.1K	﹤0.01%	647
2020 Q1	$324K	Hold	195,856	–	–	﹤0.01%	638
2019 Q4	$564K	Hold	195,856	–	–	﹤0.01%	669
2019 Q3	$1.13M	Hold	195,856	–	–	﹤0.01%	621
2019 Q2	$2.05M	Hold	195,856	–	–	﹤0.01%	605
2019 Q1	$3.44M	Hold	195,856	–	–	0.01%	540
2018 Q4	$3.45M	Sell	195,856 -79,646	-29%	-$2.36M	0.01%	545
2018 Q3	$11.3M	Sell	275,502 -9,067	-3%	-$511K	0.02%	472
2018 Q2	$16.3M	Hold	284,569	–	–	0.02%	423
2018 Q1	$13.7M	Buy	+284,569	New	+$12.6M	0.04%	319

Other funds holding COGT

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return